000 | 01866 a2200601 4500 | ||
---|---|---|---|
005 | 20250515150428.0 | ||
264 | 0 | _c20090210 | |
008 | 200902s 0 0 eng d | ||
022 | _a1053-1807 | ||
024 | 7 |
_a10.1002/jmri.21502 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuber, S | |
245 | 0 | 0 |
_aSafety of gadoversetamide in patients with acute and chronic myocardial infarction. _h[electronic resource] |
260 |
_bJournal of magnetic resonance imaging : JMRI _cDec 2008 |
||
300 |
_a1368-78 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aContrast Media _xadministration & dosage |
650 | 0 | 4 | _aElectroencephalography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xdiagnosis |
650 | 0 | 4 |
_aOrganometallic Compounds _xadministration & dosage |
700 | 1 | _aMuthupillai, R | |
700 | 1 | _aCheong, B | |
700 | 1 | _aWible, J H | |
700 | 1 | _aShah, D | |
700 | 1 | _aWoodard, P | |
700 | 1 | _aGrothues, F | |
700 | 1 | _aMahrholdt, H | |
700 | 1 | _aRochitte, C E | |
700 | 1 | _aMasoli, O | |
700 | 1 | _aKim, R J | |
700 | 1 | _aSchwaiger, C M | |
700 | 1 | _aFuisz, A | |
700 | 1 | _aKramer, C | |
700 | 1 | _avan Rossum, A C | |
700 | 1 | _aBiederman, R | |
700 | 1 | _aLombardi, M | |
700 | 1 | _aMartin, E | |
700 | 1 | _aKevorkian, R | |
700 | 1 | _aFlamm, S D | |
773 | 0 |
_tJournal of magnetic resonance imaging : JMRI _gvol. 28 _gno. 6 _gp. 1368-78 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmri.21502 _zAvailable from publisher's website |
999 |
_c18482248 _d18482248 |